- Advertise
- OLE Scientific Interchange Workshops
- About OncLive
- Editorial Board
- CureToday.com
- TargetedOnc.com
- CancerNetwork.com
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
The George Washington Cancer Center | Strategic Alliance Partners
Latest from The George Washington Cancer Center
Dr. Smith on the Rationale Behind the Fixed Duration Trial for Ibrutinib/Venetoclax in CLL
December 10, 2019
Video
Mitchell R. Smith, MD, PhD, discusses the rationale behind the trial looking at the fixed duration of the ibrutinib and venetoclax combination in chronic lymphocytic leukemia.
Dr. Smith on PI3K Inhibitors in CLL
November 02, 2019
Video
Mitchell R. Smith, MD, PhD, division director, Cancer and Blood Disorders, and professor of medicine, GW Cancer Center, discusses the use of PI3K inhibitors in chronic lymphocytic leukemia (CLL).
Dr. Tabbara on Treatment for Transplant-Eligible and -Ineligible Patients With Multiple Myeloma
November 01, 2019
Video
Imad Tabbara, MD, discusses available treatment options for transplant-eligible and -ineligible patients with multiple myeloma.
Dr. Smith on Frontline Treatment Considerations in CLL
October 24, 2019
Video
Mitchell R. Smith, MD, PhD, discusses frontline treatment considerations in patients with chronic lymphocytic leukemia.
Dr. Smith on Using Venetoclax Versus Ibrutinib in CLL
October 17, 2019
Video
Mitchell R. Smith, MD, PhD, discusses the use of venetoclax versus ibrutinib in patients with chronic lymphocytic leukemia.
Personalized, Chemo-Free Regimens Emerging in Follicular Lymphoma
October 09, 2019
Article
Kieron Dunleavy, MD, discusses emerging treatment options and when to use the watch-and-wait approach in follicular lymphoma.